ARCT-032
ARCT-032-01
Phase 2 small_molecule active
Quick answer
ARCT-032 for Cystic Fibrosis is a Phase 2 program (small_molecule) at Arcturus Therapeutics Holdings with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Arcturus Therapeutics Holdings
- Indication
- Cystic Fibrosis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active